CAS 1675248-19-7

Tofacitinib Amide (3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide)

CAS: 1675248-19-7

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi

Formel: C₁₆H₂₂N₆O₂

Farbe und Form: White Off-White Solid

Molekulargewicht: 330.18042

Ref: 45-1A03890

3-((3R,4R)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide

CAS: 1675248-19-7

Formel: C₁₆H₂₂N₆O₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 330.3849

Ref: IN-DA00ABHG

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide

CAS: 1675248-19-7

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide

Reinheit: 98%

Ref: 54-OR1036689

Tofacitinib Impurity 61

CAS: 1675248-19-7

Formel: C₁₆H₂₂N₆O₂

Farbe und Form: White To Off-White Solid

Molekulargewicht: 330.39

Ref: 4Z-T-117025

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide

CAS: 1675248-19-7

Reinheit: 98%

Molekulargewicht: 330.3919982910156

Ref: 10-F789597

Tofacitinib Impurity L

CAS: 1675248-19-7

Formel: C₁₆H₂₂N₆O₂

Molekulargewicht: 330.38

Ref: ST-EA-CP-T23006

Tofacitinib impurity L

Kontrolliertes Produkt

CAS: 1675248-19-7

Impurity Tofacitinib Impurity (T528000)
Applications Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
References Jiang, J., et. al.: J. med. Chem., 51, 8012 (2008)

Formel: C₁₆H₂₂N₆O₂

Farbe und Form: Neat

Molekulargewicht: 330.38

Ref: TR-T528015